The emerging role of hepatocyte growth factor in renal diseases

References

• Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991;3:67–85
   PubMedGoogle Scholar
• Bu X, Zhou Y, Zhang H, et al. Systemic administration of naked plasmid encoding HGF attenuates puromycin aminonucleoside-induced damage of murine glomerular podocytes. Am J Physiol Renal Physiol 2011;301:784–92
   Web of Science ®Google Scholar
• Liu Y, Centracchio JN, Lin L, et al. Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-Met and fibronectin expression. Exp Cell Res 1998;242:174–85
   PubMed Web of Science ®Google Scholar
• Rehman J, Considine RV, Bovenkerk JE, et al. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 2003;41:1408–13
   PubMed Web of Science ®Google Scholar
• Malatino LS, Cataliotti A, Benedetto FA, et al. Hepatocyte growth factor and left ventricular geometry in end-stage renal disease. Hypertension 2003;41:88–92
   PubMed Web of Science ®Google Scholar
• Yuan J, Watanabe M, Suliman M, et al. Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting. Nephrol Dial Transplant 2015;30:274–82
   PubMed Web of Science ®Google Scholar
• Mizuno S, Matsumoto K, Nakamura T, et al. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 2001; 59:1304–14
   PubMed Web of Science ®Google Scholar
• Lohr JW, Lee TP, Farooqui M, et al. Increased levels of serum hepatocyte growth factor in patients with end-stage renal disease. J Med 2000;31:131–41
   PubMedGoogle Scholar
• Zhang J, Tao LJ, Hu ZJ. Expression of serum hepatocyte growth factor in patients with acute renal failure. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2004;29:65–6
   PubMedGoogle Scholar
• Li L, He D, Yang J, et al. Cordycepin inhibits renal interstitial myofibroblast activation probably by inducing hepatocyte growth factor expression. J Pharmacol Sci 2011;117:286–94
   PubMed Web of Science ®Google Scholar
• Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 2003;327:1–23
   PubMed Web of Science ®Google Scholar
• Guoguo S, Akaike T, Tao J, et al. HGF-mediated inhibition of oxidative stress by 8-nitro-cGMP in high glucose-treated rat mesangial cells. Free Radic Res 2012;46:1238–48
   PubMed Web of Science ®Google Scholar
• Romero-Vásquez F, Chávez M, Pérez M, et al. Overexpression of HGF transgene attenuates renal inflammatory mediators, Na(+)-ATPase activity and hypertension in spontaneously hypertensive rats. Biochim Biophys Acta 2012;1822:1590–9
   PubMed Web of Science ®Google Scholar
• Enriquez-Cortina C, Almonte-Becerril M, Clavijo-Cornejo D, et al. Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage. Toxicol Sci 2013;135:26–36
   PubMed Web of Science ®Google Scholar
• Azuma J, Taniyama Y, Takeya Y, et al. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther 2006;13:1206–13
   PubMed Web of Science ®Google Scholar
• Esposito C, Parrilla B, De Mauri A, et al. Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli. Kidney Int 2005;67:2143–50
   PubMed Web of Science ®Google Scholar
• Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 2004;287:7–16
   PubMed Web of Science ®Google Scholar
• Mungunsukh O, Day RM. Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism. Mol Biol Cell 2013;24:2088–97
   PubMed Web of Science ®Google Scholar
• Cui Q, Fu S, Li Z. Hepatocyte growth factor inhibits TGF-β1-induced myofibroblast differentiation in tendon fibroblasts: role of AMPK signaling pathway. J Physiol Sci 2013;63:163–70
   PubMed Web of Science ®Google Scholar
• Wang HY, Yang LZ, Gu CM, et al. Pathological changes, TGF-β1 expression, and the effects of hepatocyte growth factor in 5/6 nephrectomized rats. Ren Fail 2014;36:393–9
   PubMed Web of Science ®Google Scholar
• Dworkin LD, Gong R, Tolbert E, et al. Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury. Kidney Int 2004;65:409–19
   PubMed Web of Science ®Google Scholar
• Clavijo-Cornejo D, Enriquez-Cortina C, López-Reyes A, et al. Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes. Biochimie 2013;95:1177–84
   PubMed Web of Science ®Google Scholar
• Cui Q, Wang Z, Jiang D, et al. HGF inhibits TGF-β1-induced myofibroblast differentiation and ECM deposition via MMP-2 in Achilles tendon in rat. Eur J Appl Physiol 2011;111:1457–63
   PubMed Web of Science ®Google Scholar
• Narmada BC, Chia SM, Tucker-Kellogg L, et al. HGF regulates the activation of TGF-β1 in rat hepatocytes and hepatic stellate cells. J Cell Physiol 2013;228:393–401
   PubMed Web of Science ®Google Scholar
• Chen HT, Tsou HK, Chang CH, et al. Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway. PLoS One 2012;7:e38378
   PubMed Web of Science ®Google Scholar
• Matsumura A, Kubota T, Taiyoh H, et al. HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells. Int J Oncol 2013;42:535–42
   PubMed Web of Science ®Google Scholar
• Moniz S, Sousa M, Moraes BJ, et al. HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR. ACS Chem Biol 2013;8:432–42
   PubMed Web of Science ®Google Scholar
• Shen YH, Jiang HX, Qin SY, et al. Activation of hepatocyte growth factor promotes apoptosis of hepatic stellate cells via the Rho pathway. Zhonghua Gan Zang Bing Za Zhi 2014;22:136–41
   PubMedGoogle Scholar
• Koraishy FM, Silva C, Mason S, et al. Hepatocyte growth factor (Hgf) stimulates low density lipoprotein receptor-related protein (Lrp) 5/6phosphorylation and promotes canonical Wnt signaling. J Biol Chem 2014;289:14341–50
   PubMed Web of Science ®Google Scholar
• Muñoz Ú, Puche JE, Hannivoort R, et al. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1. Mol Cancer Res 2012;10:1216–27
   PubMed Web of Science ®Google Scholar
• Liu HY, Jia XQ, Gao LX, et al. Hepatocyte growth factor regulates HLX1 gene expression to modulate HTR-8/SVneo trophoblast cells. Reprod Biol Endocrinol 2012;10:83–91
   PubMed Web of Science ®Google Scholar
• Usatyuk PV, Fu P, Mohan V, et al. Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells. J Biol Chem. 2014;289:13476–91
   PubMed Web of Science ®Google Scholar
• Lee KH, Koh SA, Kim JR, et al. Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells. Oncol Res 2013;20:393–402
   PubMed Web of Science ®Google Scholar
• Gong R, Rifai A, Ge Y, et al. Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells. J Biol Chem 2008;283:7401–10
   PubMed Web of Science ®Google Scholar
• Gong R, Rifai A, Dworkin LD. Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin. Kidney Int 2006;69:1166–74
   PubMed Web of Science ®Google Scholar
• Wen X, Li Y, Hu K, et al. Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. Am J Pathol 2005;167:947–57
   PubMed Web of Science ®Google Scholar
• Heiz M, Grünberg J, Schubiger PA, et al. Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain. J Biol Chem 2004;279:31149–56
   PubMed Web of Science ®Google Scholar
• Gong R, Rifai A, Tolbert EM, et al. Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J Am Soc Nephrol 2003;14:3047–60
   PubMed Web of Science ®Google Scholar
• Kobayashi E, Sasamura H, Mifune M, et al. Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts. Kidney Int 2003;64:1179–88
   PubMed Web of Science ®Google Scholar
• Tahara Y, Ido A, Yamamoto S, et al. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther 2003;307:146–51
   PubMed Web of Science ®Google Scholar
• Jin M, Defoe DM, Wondergem R. Hepatocyte growth factor/scatter factor stimulates Ca2+-activated membrane K+ current and migration of MDCK II cells. J Membr Biol 2003;191:77–86
   PubMed Web of Science ®Google Scholar
• Crljen V, Volinia S, Banfic H, et al. Hepatocyte growth factor activates phosphoinositide 3-kinase C2 beta in renal brush-border plasma membranes. Biochem J 2002;365:791–9
   PubMed Web of Science ®Google Scholar
• Radhakrishnan N, Bhaskaran M, Singhal PC, et al. Hepatocyte growth factor modulates H2O2-induced mesangial cell apoptosis through induction of heme oxygenase-1. Nephron Physiol 2005;101:92–8
   Google Scholar
• Gong R, Rifai A, Dworkin LD, et al. Activation of PI3K-Akt-GSK3beta pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cells. Biochem Biophys Res Commun 2005;330:27–33
   PubMed Web of Science ®Google Scholar
• Higuchi T, Orita T, Katsuya K, et al. MUC20 suppresses the hepatocyte growth factor- induced Grb2-Ras pathway by binding to a multifunctional docking site of met. Mol Cell Biol 2004;24:7456–68
   PubMed Web of Science ®Google Scholar
• Mou S, Wang Q, Shi B, et al. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts. Kaohsiung J Med Sci 2009;25:577–87
   PubMed Web of Science ®Google Scholar
• Buurman R, Gürlevik E, Schäffer V, et al. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology 2012;143:811–20
   PubMed Web of Science ®Google Scholar
• Li Y, Wen X, Spataro BC, et al. Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. J Am Soc Nephrol 2006;17:54–65
   PubMed Web of Science ®Google Scholar
• Serrano I, Díez-Marqués ML, Rodríguez-Puyol M, et al. Integrin-linked kinase (ILK) modulates wound healing through regulation of hepatocyte growth factor (HGF). Exp Cell Res 2012;318:2470–81
   PubMed Web of Science ®Google Scholar
• Huang J, Dong B, Zhang J, et al. miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma. Tumour Biol 2014;35:5833–43
   PubMed Web of Science ®Google Scholar
• Uchida T, Hazekawa M, Yoshida M, et al. A novel long-acting prostacyclin agonist (ONO-1301) with an angiogenic effect: promoting synthesis of hepatocyte growth factor and increasing cyclic AMP concentration via IP-receptor signaling. J Pharmacol Sci 2013;123:392–401
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang XF, Lu X, et al. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology 2014;59:1874–85
   PubMed Web of Science ®Google Scholar
• Nicastro HL, Firestone GL, Bjeldanes LF. 3,3′-diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells. J Nutr Biochem 2013;24:1882–8
   PubMed Web of Science ®Google Scholar
• Barnaeva E, Nadezhda A, Hannappel E, et al. Thymosin beta4 upregulates the expression of hepatocyte growth factor and downregulates the expression of PDGF-beta receptor in human hepatic stellate cells. Ann N Y Acad Sci 2007;1112:154–60
   PubMed Web of Science ®Google Scholar
• Garnett J, Chumbalkar V, Vaillant B, et al. Regulation of HGF expression by ΔEGFR- mediated c-Met activation in glioblastoma cells. Neoplasia 2013;15:73–84
   PubMed Web of Science ®Google Scholar
• Li Y, Spataro BC, Yang J, et al. 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int 2005;68:1500–10
   PubMed Web of Science ®Google Scholar
• Koliaraki V, Roulis M, Kollias G, et al. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis. J Clin Invest 2012;122:4231–42
   PubMed Web of Science ®Google Scholar
• Bozkaya G, Korhan P, Cokaklı M, et al. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Mol Cancer 2012;11:64
   PubMed Web of Science ®Google Scholar
• Wang PP, Xie DY, Liang XJ, et al. HGF and direct mesenchymal stem cells contact synergize to inhibit hepatic stellate cells activation throughTLR4/NF-kB pathway. PLoS One 2012;7:e43408
   PubMed Web of Science ®Google Scholar
• Yoon YS, Lee YJ, Choi JY, et al. Coordinated induction of cyclooxygenase-2/prostaglandin E2 and hepatocyte growth factor by apoptotic cells prevents lung fibrosis. J Leukoc Biol 2013;94:1037–49
   PubMed Web of Science ®Google Scholar
• Zhang A, Wang MH, Dong Z, et al. Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor. Am J Physiol Renal Physiol 2006;291:F1323–31
   PubMed Web of Science ®Google Scholar
• Kuroiwa T, Iwasaki T, Imado T, et al. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther 2006;8:R123
   PubMed Web of Science ®Google Scholar
• Kato T, Mizuno S, Nakamura T, et al. Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice. Nephrology (Carlton) 2011;16:310–18
   PubMed Web of Science ®Google Scholar
• Stewart N, Chade AR. Renoprotective effects of hepatocyte growth factor in the stenotic kidney. Am J Physiol Renal Physiol 2013;304:F625–33
   PubMed Web of Science ®Google Scholar
• Wang HY, Yang LZ, Cui MJ. Hepatocyte growth factor-induced amelioration in chronic renal failure is associated with reduced expression of α-smooth muscle actin. Ren Fail 2012;34:862–70
   PubMed Web of Science ®Google Scholar
• Wang HY, Wang YJ, Cui MJ, et al. Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1. Indian J Biochem Biophys 2011;48:308–15
   PubMed Web of Science ®Google Scholar
• Oku M, Okumi M, Shimizu A, et al. Hepatocyte growth factor sustains T regulatory cells and prolongs the survival of kidney allografts in major histocompatibility complex-inbred CLAWN-miniature swine. Transplantation 2012;93:148–55
   PubMed Web of Science ®Google Scholar
• da Silva CG, Maccariello ER, Wilson SW, et al. Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation. J Cell Physiol 2012;227:1382–90
   PubMed Web of Science ®Google Scholar
• Agustian PA, Schiffer M, Gwinner W, et al. Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy. Am J Pathol 2011;178:2007–19
   PubMed Web of Science ®Google Scholar
• Li W, Jiang H, Feng JM. Isogenic mesenchymal stem cells transplantation improves a rat model of chronic aristolochic acid nephropathy via upregulation of hepatic growth factor and downregulation of transforming growth factor β1. Mol Cell Biochem 2012;368:137–45
   PubMed Web of Science ®Google Scholar
• Chen X, Chen Z, Wang H, et al. Plasmid pUDK-HGF encoding human hepatocyte growth factor gene attenuates gentamicin-induced kidney injury in rats. Exp Toxicol Pathol 2013;65:541–7
   PubMed Web of Science ®Google Scholar
• Flaquer M, Franquesa M, Vidal A, et al. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair indb/db mice as a model of diabetes. Diabetologia 2012;55:2059–68
   PubMed Web of Science ®Google Scholar
• Kusunoki H, Taniyama Y, Azuma J, et al. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade. Hypertension 2012;59:308–16
   PubMed Web of Science ®Google Scholar
• Iekushi K, Taniyama Y, Azuma J, et al. Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblasts. J Hypertens 2010;28:2454–61
   PubMed Web of Science ®Google Scholar
• Chen Y, Qian H, Zhu W, et al. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev 2011;20:103–13
   PubMed Web of Science ®Google Scholar
• Dai C, Saleem MA, Holzman LB, et al. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Kidney Int 2010;77:962–73
   PubMed Web of Science ®Google Scholar
• Mou S, Wang Q, Shi B, et al. Hepatocyte growth factor ameliorates progression of interstitial injuries in tubular epithelial cells. Scand J Urol Nephrol 2010;44:121–8
   PubMed Web of Science ®Google Scholar
• Ma H, Saenko M, Opuko A, et al. Deletion of the Met receptor in the collecting duct decreases renal repair following ureteral obstruction. Kidney Int. 2009;76:868–76
   PubMed Web of Science ®Google Scholar
• Yamasaki N, Nagano T, Mori-Kudo I, et al. Hepatocyte growth factor protects functional and histological disorders of HgCl(2)-induced acute renal failure mice. Nephron 2002;90:195–205
   PubMed Web of Science ®Google Scholar
• Dai C, Yang J, Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 2002;13:411–22
   PubMed Web of Science ®Google Scholar
• Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002;13:96–107
   PubMed Web of Science ®Google Scholar
• Wu JH, Billings BJ, Balkovetz DF. Hepatocyte growth factor alters renal epithelial cell susceptibility to uropathogenic Escherichia coli. J Am Soc Nephrol 2001;12:2543–53
   PubMed Web of Science ®Google Scholar
• Yang J, Dai C, Liu Y. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther 2001;8:1470–9
   PubMed Web of Science ®Google Scholar
• Vijayan A, Martin DR, Sadow JL, et al. Hepatocyte growth factor inhibits apoptosis after ischemic renal injury in rats. Am J Kidney Dis 2001;38:274–8
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Morishita R, Moriguchi A, et al. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats. Hypertension 1999;34:279–84
   PubMed Web of Science ®Google Scholar
• Mizuno S, Kurosawa T, Matsumoto K, et al. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998;101:1827–34
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun AM, Dworkin LD. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun 1998;246:821–6
   PubMed Web of Science ®Google Scholar
• Taman M, Liu Y, Tolbert E, et al. Increase urinary hepatocyte growth factor excretion in human acute renal failure. Clin Nephrol 1997;48:241–5
   PubMed Web of Science ®Google Scholar
• Nakatani T, Kim T, Uchida J, et al. Hepatocyte growth factor ameliorates renal hemodynamic disorder after ischemia/reperfusion. Int J Mol Med 2002;10:217–19
   PubMed Web of Science ®Google Scholar
• Wei MJ, Wu WL, Chen MY. Expression of TGF-beta and hepatocyte growth factor in kidney tissues of children with primary focal segmental glomerular sclerosis. Zhongguo Dang Dai Er Ke Za Zhi 2010;12:630–3
   PubMedGoogle Scholar
• Fornoni A, Li H, Foschi A, et al. Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol 2001;158:275–80
   PubMed Web of Science ®Google Scholar
• Mason S, Hader C, Marlier A, et al. Met activation is required for early cytoprotection after ischemic kidney injury. J Am Soc Nephrol 2014;25:329–37
   PubMed Web of Science ®Google Scholar
• Randers E, Erlandsen EJ, Kristensen JH, et al. Serum hepatocyte growth factor levels in patients with chronic renal disease – effect of GFR and pathogenesis. Scand J Clin Lab Invest 2001;61:615–19
   PubMed Web of Science ®Google Scholar
• Lohr JW, Lee TP, Farooqui M, et al. Increased levels of serum hepatocyte growth factor in patients with end-stage renal disease. J Med 2000;31:131–41
   PubMedGoogle Scholar
• Malatino LS, Mallamaci F, Benedetto FA, et al. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis 2000;36:945–52
   PubMed Web of Science ®Google Scholar
• Mizuno S, Matsumoto K, Kurosawa T, et al. Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int 2000;57:937–48
   PubMed Web of Science ®Google Scholar
• Taniguchi Y, Yorioka N, Yamashita K, et al. Localization of hepatocyte growth factor and tubulointerstitial lesions in IgA nephropathy. Am J Nephrol 1997;17:413–16
   PubMed Web of Science ®Google Scholar
• Rampino T, Libetta C, De Simone W, et al. Hemodialysis stimulates hepatocyte growth factor release. Kidney Int 1998;53:1382–8
   PubMed Web of Science ®Google Scholar
• Yo Y, Morishita R, Yamamoto K, et al. Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease. Kidney Int 1998;53:50–8
   PubMed Web of Science ®Google Scholar
• Capuano A, Costanzi S, Peluso G, et al. Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematous nephritis. Arthritis Rheum 2006;54:3633–9
   PubMed Web of Science ®Google Scholar
• Rampino T, Gregorini M, Camussi G, et al. Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis. Nephrol Dial Transplant 2005;20:1066–74
   PubMed Web of Science ®Google Scholar
• Zhou D, Tan RJ, Lin L, et al. Activation of hepatocyte growth factor receptor, c-Met, in renal tubules is required for renoprotection after acute kidney injury. Kidney Int 2013;84:509–20
   PubMed Web of Science ®Google Scholar
• Nishida M, Kawakatsu H, Ishiwari K, et al. Serum hepatocyte growth factor levels in patients with renal diseases. Am J Nephrol 1999;19:509–12
   PubMed Web of Science ®Google Scholar